BioSpace News Archive

Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Cardiothoracic and Vascular Anesthesia.

Dalrada Corporation (OTCQB: DFCO, “Dalrada”), an innovator in healthcare, green energy, and technology, today announced that the Company completed a second clinical trial on its patent-pending cerVIA™ (visual inspection with acetic acid) kit used to screen for cervical cancer, allowing preventative measures in India with one hundred women.

Tremelimumab accepted under Priority Review in the US for patients with unresectable liver cancer in combination with Imfinzi.

Lucid Diagnostics Inc. today announced that the Company will host a business update conference call on Wednesday, May 11, 2022, at 4:30 PM EDT.

Nemaura Medical, Inc. announces today that CEO Dr. Faz Chowdhury will present virtually at the Planet MicroCap Showcase 2022.

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the publication of preclinical data for WVE-004, the company’s clinical candidate for C9orf72-associated amyotrophic lateral sclerosis (C9-ALS) and frontotemporal dementia (C9-FTD), in Molecular Therapy Nucleic Acids (MTNA).

NanoVibronix, Inc. today announced that its PainShield Plus and PainShield Monthly Kit products have been added to the Federal Supply Schedule (FSS) through a service disabled veteran organization.

Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces that Prime Discoveries has successfully developed CovidDetect™, a rapid isothermal amplification diagnostic assay for detecting SARS-CoV-2.

Clarus Therapeutics Holdings, Inc. today announced the pricing of its underwritten public offering of (i) units consisting of 26,680,720 shares .

Braintale, a medtech that is deciphering white matter, spin off from the Assistance Publique-Hôpitaux de Paris, showcases, with Minoryx, a biotechnology company developing a treatment for X-linked Adrenoleukodystrophy, the results of the multicentric ADVANCE sub study with Braintale biomarker platform on the occasion of the American Academy of Neurology.